Applicant, as named in the Orange Book
Sanofi Aventis Us
Next listed expiry: Jevtana Kit on 27 Apr 2031. 3 products with live protection, 12 without.
Products with listed protection
| Drug | Earliest generic entry |
|---|---|
| Jevtana Kit cabazitaxel | 27 Apr 2031 |
| Multaq dronedarone hydrochloride | 30 Jun 2031 |
| Aubagio · 2 strengths teriflunomide | 4 Aug 2034 |
Recent events
- 25 Oct 2026Avapro · Generic approved 4 Nov 2025
- 25 Oct 2026Clomid · Generic approved 3 Oct 2025
- 25 Oct 2026Calcimar · Generic approved 4 Mar 2026
- 25 Oct 2026Calcimar · Generic approved 26 Sep 2025
- 25 Oct 2026Rifadin · Generic approved 29 Jun 2026
- 25 Oct 2026Lovenox (Preservative Free) · Generic approved 7 Jan 2026
- 25 Oct 2026Clomid · Generic approved 15 May 2026
- 25 Oct 2026Priftin · First generic approved 23 Jun 2026
- 25 Oct 2026Priftin · Generic approved 23 Jun 2026
- 25 Oct 2026Clomid · Generic approved 17 Oct 2025
- 25 Oct 2026Eloxatin · Generic approved 15 Jan 2026
Products without listed protection (12)
| Drug | Earliest generic entry |
|---|---|
| Arava · 2 strengths leflunomide | open now |
| Avalide · 2 strengths hydrochlorothiazide; irbesartan | open now |
| Avapro · 2 strengths irbesartan | open now |
| Diabeta · 3 strengths glyburide | open now |
| Ferrlecit sodium ferric gluconate complex | open now |
| Lovenox enoxaparin sodium | open now |
| Lovenox (Preservative Free) · 7 strengths enoxaparin sodium | open now |
| Plavix · 2 strengths clopidogrel bisulfate | open now |
| Priftin rifapentine | open now |
| Primaquine primaquine phosphate | open now |
| Rifadin rifampin | open now |
| Taxotere docetaxel | open now |